News Daily News OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests Todd Neale July 16, 2018
News Daily News CMS Taking Another Look at Volume Requirements for TAVR Programs Todd Neale June 28, 2018
News Conference News The Structural Heart Disease Summit 2018 Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR? Shelley Wood June 21, 2018
News Industry News Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR May 24, 2018
News Industry News Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease May 23, 2018
News Conference News EuroPCR 2018 Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted Caitlin E. Cox May 23, 2018
News Conference News HRS 2018 Military Veterans With PTSD Are at Risk for A-fib Todd Neale May 10, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Industry News Conavi Medical Announces FDA 510(k) Clearance of the Novasight Hybrid System with Simultaneous Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) Capabilities May 02, 2018
News Conference News SCAI 2018 Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes Shelley Wood April 28, 2018
News Daily News Uncomplicated TLR After PCI Linked With Worse Mortality Michael O'Riordan April 20, 2018
News Daily News FDA: Battery, Cybersecurity Issues With ICDs and CRT-Ds Now Have Firmware Fix Todd Neale April 17, 2018
News Industry News Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease April 11, 2018
News Industry News Boston Scientific Announces Acquisition of Securus Medical Group, Inc. April 10, 2018
News Conference News ACC 2018 Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 Yael L. Maxwell March 19, 2018
News Conference News ACC 2018 Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4 Todd Neale March 13, 2018